Zhu Y - Search Results

1

The effects of small interfering RNA-targeting tissue factor on an in vitro model of neovascularization.

Peng W, Yu Y, Li T, Zhu Y, Chen H. Peng W, et al. Among authors: zhu y. Mol Vis. 2013 Jun 11;19:1296-303. Print 2013. Mol Vis. 2013. PMID: 23805036 Free PMC article.

2

Expression and function of tetraspanin 1 in esophageal carcinoma.

Gu T, Chen W, Chen L, Wang G, Li T, Zhu Y, Gao X. Gu T, et al. Among authors: zhu y. Oncol Lett. 2017 Dec;14(6):6815-6822. doi: 10.3892/ol.2017.7028. Epub 2017 Sep 22. Oncol Lett. 2017. PMID: 29422958 Free PMC article.

3

Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF.

Wu YY, Chen L, Wang GL, Zhang YX, Zhou JM, He S, Qin J, Zhu YY. Wu YY, et al. J Mol Histol. 2013 Aug;44(4):433-45. doi: 10.1007/s10735-012-9480-5. Epub 2013 May 1. J Mol Histol. 2013. PMID: 23636606

4

Double-stranded RNA-induced TLR3 activation inhibits angiogenesis and triggers apoptosis of human hepatocellular carcinoma cells.

Guo Z, Chen L, Zhu Y, Zhang Y, He S, Qin J, Tang X, Zhou J, Wei Y. Guo Z, et al. Among authors: zhu y. Oncol Rep. 2012 Feb;27(2):396-402. doi: 10.3892/or.2011.1538. Epub 2011 Nov 8. Oncol Rep. 2012. PMID: 22075935

5

Inhibitory effect of dsRNA TLR3 agonist in a rat hepatocellular carcinoma model.

Xu YY, Chen L, Zhou JM, Wu YY, Zhu YY. Xu YY, et al. Mol Med Rep. 2013 Oct;8(4):1037-42. doi: 10.3892/mmr.2013.1646. Epub 2013 Aug 19. Mol Med Rep. 2013. PMID: 23970360

6

The effect of NET-1 on the proliferation, migration and endocytosis of the SMMC-7721 HCC cell line.

Wang GL, Chen L, Wei YZ, Zhou JM, Wu YY, Zhang YX, Qin J, Zhu YY. Wang GL, et al. Oncol Rep. 2012 Jun;27(6):1944-52. doi: 10.3892/or.2012.1698. Epub 2012 Feb 28. Oncol Rep. 2012. PMID: 22378020

7

Knockdown of TSPAN1 by RNA silencing and antisense technique inhibits proliferation and infiltration of human skin squamous carcinoma cells.

Chen L, Zhu Y, Li H, Wang GL, Wu YY, Lu YX, Qin J, Tuo J, Wang JL, Zhu J. Chen L, et al. Among authors: zhu y, zhu j. Tumori. 2010 Mar-Apr;96(2):289-95. doi: 10.1177/030089161009600217. Tumori. 2010. PMID: 20572588

8

TLR3 dsRNA agonist inhibits growth and invasion of HepG2.2.15 HCC cells.

Chen L, Xu YY, Zhou JM, Wu YY, E Q, Zhu YY. Chen L, et al. Oncol Rep. 2012 Jul;28(1):200-6. doi: 10.3892/or.2012.1791. Epub 2012 Apr 30. Oncol Rep. 2012. PMID: 22552584

9

A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo.

Xu YY, Chen L, Wang GL, Zhou JM, Zhang YX, Wei YZ, Zhu YY, Qin J. Xu YY, et al. BMC Cancer. 2013 Nov 6;13:527. doi: 10.1186/1471-2407-13-527. BMC Cancer. 2013. Retraction in: BMC Cancer. 2023 Jul 7;23(1):636. doi: 10.1186/s12885-023-11135-3 PMID: 24195809 Free PMC article. Retracted.

10

[Expression and significance of NET-1 protein in hepatocellular carcinoma].

Chen L, Li XY, Wang Y, Zhu YY, Zhu JW. Chen L, et al. Among authors: zhu yy, zhu jw. Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):917-21. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18478931 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,116 results

Search Page

Filters